Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid

NCT00584935 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Ocular Cicatricial Pemphigoid

Interventions

DRUG: Rituximab

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]